Development Period Security Sample Clauses

Development Period Security. To guarantee undertaking the performance of Seller's obligations under the Agreement for the period prior to the Commercial Operations Date (including but not limited to Seller's obligation to meet the Guaranteed Commercial Operations Date), Seller shall provide 50% of the Development Period Security to Company within ten (10) Days of Execution Date of the Agreement and the remaining 50% of the Development Period Security within ten (10) Business Days of the execution of the Interconnection Requirements Amendment.
Sample 1Sample 2Sample 3See All (33)
AutoNDA by SimpleDocs
Development Period Security. In order to secure Seller's obligations prior to Commercial Operation of the Facility, at Seller's expense, Seller shall post and maintain in favor of Buyer the Development Period Security in accordance with the following terms and conditions:
Sample 1Sample 2Sample 3
Development Period Security. On or before August 1, 2008, Seller shall be required to establish collateral in favor of Buyer by providing Buyer with a Letter of Credit from a Qualified Issuer to secure Seller’s obligations under this Agreement in the period between the Execution Date and the Initial Delivery Date (the “Development Period Security”). The Development Period Security to be provided pursuant to the first sentence of this Section 8.1(a) shall be in an amount equal to three million dollars ($3,000,000) and shall be maintained in full force and effect by Seller until its expiry pursuant to the terms hereof (subject to Section 2.3). By not later than fifteen (15) days after the Effective Date, the amount of the Development Period Security shall be increased to an amount equal to six million dollars ($6,000,000) and shall be maintained in full force and effect by Seller until its expiry pursuant to the terms hereof. In the event Buyer draws on the Development Period Security to pay Delay Damages, Seller shall promptly, and in all events within three (3) Business Days, replenish the amount of the Development Period Security by the amount drawn; provided, however, Seller shall not be required to replenish the Development Period Security in excess of the total amount of the Maximum Delay Damages. Buyer shall have the right to terminate the Agreement and retain the initial installment of the Development Period Security as liquidated damages if Seller fails to provide the increased amount of Development Period Security within fifteen (15) days after the Effective Date as set forth in this Section 8.1(a), and such failure shall be considered an Event of Default of Seller.
Sample 1
Development Period Security. To guarantee undertaking the performance of Subscriber Organization's obligations under the Agreement for the period prior to the Commercial Operations Date (including but not limited to Subscriber Organization's obligation to meet the Guaranteed Commercial Operations Date), Subscriber Organization shall provide 50% of the Development Period Security to Company within ten (10) Days of Execution Date of the Agreement and the remaining 50% of the Development Period Security within ten
Sample 1
Development Period Security. (a) Seller shall be required to establish collateral in favor of Buyer by providing Buyer with cash, a Letter of Credit from a Qualified Issuer or a performance and payment bond substantially in the form of Exhibit I from a Qualified Issuer, or any combination thereof, provided that, unless otherwise agreed to by Buyer in writing, in no event may the amount of security posted by Seller in the form of a payment bond exceed forty percent (40%) of Seller’s Developer Period Security requirement, to secure Seller’s obligations under this Agreement for the period between the Execution Date and the Commercial Operation Date (the “Development Period Security”).
Sample 1
Development Period Security. Company shall draw upon the Development Period Security established pursuant to Section 7.1 (Security Fund) on a monthly basis for payment of the total Milestone Delay Damages and Daily Delay Damages incurred by Seller during the preceding Calendar Month. If the Development Period Security is at any time insufficient to pay the amount of the draw to which Company is then entitled, Seller shall pay any such deficiency to Company promptly upon demand.
Sample 1
Development Period Security. To guarantee Seller's undertaking to meet the Commercial Operation Date Deadline, Seller shall provide financial security to Company within seven (7) Days of the date upon which the PUC Approval of Amendment Order becomes a non‑appealable order within the meaning of the definition of a Non-appealable PUC Approval of Amendment Order in Section 25.12(B) (Non-appealable PUC Approval of Amendment Order) in an amount equal to $40/kW of the Committed Capacity (the “Development Period Security”). When the Commercial Operation Date has been achieved, the Development Period Security minus an amount, if any, for Daily Delay Damages that is due and owing to Company but not previously paid by Seller, shall be converted to Operating Period Security unless the Parties otherwise agree.
Sample 1
AutoNDA by SimpleDocs
Development Period Security 
Sample 1Sample 2

Related to Development Period Security

  • Development Program A. Development activities to be undertaken (Please break activities into subunits with the date of completion of major milestones)

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Concession Area, including its abandonment.

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!